Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Xiaofan Hu,Mingyang Bao,Jiacheng Huang,Lin Zhou,Shusen Zheng

DOI: https://doi.org/10.3389/fonc.2020.617539

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:CORRECTION article Front. Oncol., 20 November 2020Sec. Molecular and Cellular Oncology Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.617539
Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Sheng Liu,Wenting Tang,Jing Cao,Mei Shang,Sun Hengchang,Jiao Gong,Bo Hu

DOI: https://doi.org/10.3389/fgene.2024.1357409

IF: 3.7

2024-01-26

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.904114.].

genetics & heredity
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism

Jie Wen,Abudureyimujiang Aili,Yao Xue Yan,YuLin Lai,Shaoqing Niu,Shasha He,Xiaokai Zhang,Guixiong Zhang,Jiaping Li

DOI: https://doi.org/10.3389/fonc.2022.1038279

IF: 4.7

2022-10-26

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.977348.].

oncology
Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Yangyang Guo,Kenan Cen,Qiaoqiao Chen,Ying Dai,Yifeng Mai,Kai Hong

DOI: https://doi.org/10.3389/fimmu.2023.1229541

IF: 7.3

2023-06-05

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1128390.].

immunology
Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis

Yong-Zheng Zhang,Amir Zeb,Lu-Feng Cheng

DOI: https://doi.org/10.3389/fimmu.2023.1168774

IF: 7.3

2023-02-28

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.1032819.].

immunology
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang,Xiaoqin He,Yue Li,Yangtao Xu,Wenliang Chen,Xin Liu,Xinyao Hu,Lin Xiong,Ximing Xu

DOI: https://doi.org/10.3389/fmolb.2021.826905

IF: 6.113

2021-12-22

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.702206.].

biochemistry & molecular biology
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Fang-Ze Wei,Shi-Wen Mei,Zhi-Jie Wang,Jia-Nan Chen,Hai-Yu Shen,Fu-Qiang Zhao,Juan Li,Zheng Liu,Qian Liu

DOI: https://doi.org/10.3389/fonc.2020.634122

IF: 4.7

2020-12-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.573295.].

oncology
Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Wei Zhang,Weiwei Wang,Junlu Wu,Jiale Tian,Wenhui Yan,Yi Yuan,Yiwen Yao,Anquan Shang,Wenqiang Quan

DOI: https://doi.org/10.3389/fonc.2022.1118042

2022-12-15

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.942964.].
Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Qiang Zhang,Hua Zhong,Yinchun Fan,Qian Liu,Jiancheng Song,Shengtao Yao,Fang Cao

DOI: https://doi.org/10.3389/fbioe.2020.599544

IF: 5.7

2020-10-23

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00592.].

multidisciplinary sciences
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Tingting Deng,Yang Liu,Jialang Zhuang,Yizhe Tang,Qin Huo

DOI: https://doi.org/10.3389/fonc.2022.979968

IF: 4.7

2022-08-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.632042.].

oncology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC

Xiao Wang,Chao Liang,Xin Yao,Ruo-Han Yang,Zhan-Sheng Zhang,Fan-Ye Liu,Wen-Qi Li,Shu-Hua Pei,Jing Ma,Song-Qiang Xie,Dong Fang

DOI: https://doi.org/10.3389/fphar.2021.724799

IF: 5.6

2021-07-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.577108.].

pharmacology & pharmacy
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Corrigendum: Lipid metabolism and tumor immunotherapy

Yue Wang,Zongjin Guo,Adamu Danbala Isah,Shuangwei Chen,Yongfei Ren,Huazhong Cai

DOI: https://doi.org/10.3389/fcell.2024.1349379

IF: 5.5

2024-01-26

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2023.1187989.].

cell biology,developmental biology

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Corrigendum: Lipid metabolism and tumor immunotherapy